Publicacións nas que colabora con Juan Francisco Arenillas Lara (21)

2024

  1. Sex-Stratified Genome-Wide Association Study in the Spanish Population Identifies a Novel Locus for Lacunar Stroke

    Stroke, Vol. 55, Núm. 10, pp. 2462-2471

2022

  1. A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype

    Frontiers in Cardiovascular Medicine, Vol. 9

  2. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  3. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2021

  1. Rp11-362k2.2:Rp11-767i20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma. a gwas meta-analysis

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  2. Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma

    Brain, Vol. 144, Núm. 8, pp. 2416-2426

2014

  1. Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment

    Neurologia

  2. Guía para el tratamiento del infarto cerebral agudo

    Neurologia

  3. Guía para el tratamiento preventivo del ictus isquémico y AIT (II). Recomendaciones según subtipo etiológico

    Neurologia

2013

  1. Guías de actuación clínica en la hemorragia intracerebral

    Neurologia

  2. Los costes del ictus en España según su etiología. El protocolo del estudio CONOCES

    Neurologia, Vol. 28, Núm. 6, pp. 332-339

2012

  1. Guía para el tratamiento preventivo del ictus isquémico y AIT (I). Actuación sobre los factores de riesgo y estilo de vida

    Neurologia

2011

  1. Plan de asistencia sanitaria al ICTUS II. 2010

    Neurologia, Vol. 26, Núm. 7, pp. 383-396

2009

  1. The metabolic syndrome is associated with a higher resistance to intravenous thrombolysis for acute ischemic stroke in women than in men

    Stroke, Vol. 40, Núm. 2, pp. 344-349

2008

  1. Biological signatures of brain damage associated with high serum ferritin levels in patients with acute ischemic stroke and thrombolytic treatment

    Disease Markers, Vol. 25, Núm. 3, pp. 181-188

  2. Body temperature and response to thrombolytic therapy in acute ischaemic stroke

    European Journal of Neurology, Vol. 15, Núm. 12, pp. 1384-1389

  3. Metabolic syndrome and resistance to IV thrombolysis in middle cerebral artery ischemic stroke

    Neurology, Vol. 71, Núm. 3, pp. 190-195

2007

  1. Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke

    Stroke, Vol. 38, Núm. 1, pp. 90-95

  2. Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: A multicenter confirmatory study

    Stroke, Vol. 38, Núm. 6, pp. 1855-1859

  3. The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome

    Stroke, Vol. 38, Núm. 10, pp. 2759-2764